Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report. [PDF]
Gummlich BPM +2 more
europepmc +1 more source
Influence of xanthine oxidase and inosine monophosphate dehydrogenase polymorphisms on 6-mercaptopurine treatment response in pediatric acute lymphoblastic leukemia. [PDF]
Sabirova Z +10 more
europepmc +1 more source
TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia. [PDF]
Jantararoungtong T +12 more
europepmc +1 more source
Impact of the loss of slc43a3 on 6-mercaptopurine absorption and tissue distribution in mice. [PDF]
Sayler AL, Dean H, Hammond JR.
europepmc +1 more source
Hepatotoxicity of 6-Mercaptopurine and Azathioprine [PDF]
openaire +2 more sources
Adherence to 6-Mercaptopurine (6-MP) and Habit Strength in Pediatric Acute Lymphoblastic Leukemia (ALL). [PDF]
Yang MM +9 more
europepmc +1 more source
Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine. [PDF]
Lambert-Fliszar F +5 more
europepmc +1 more source
Language, 6-mercaptopurine adherence, and relapse in children with acute lymphoblastic leukemia. [PDF]
Robles J +6 more
europepmc +1 more source
Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review. [PDF]
Gordon M +6 more
europepmc +1 more source
Social Determinants of 6-Mercaptopurine Adherence Among Patients with Acute Lymphoblastic Leukemia/Lymphoma: A Cross-Sectional Analysis. [PDF]
El-Khatib A +3 more
europepmc +1 more source

